GAGNON SECURITIES LLC

13F Filings History

Latest 13F report
Q4 2024 - Jan 24, 2025
Value $
$496M
Signature - Title
Lisa Ferrante - Chief Compliance Officer
Location
New York, NY
Summary
This page shows a list of all the recent 13F filings made by GAGNON SECURITIES LLC. Form 13F is required to be filed within 45 days of the end of a calendar quarter. GAGNON SECURITIES LLC reported 91 stock holdings with total value $496M as of Q4 2024. Top holdings included AL, ISRG, CDNA, ENSG, and WGS.
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Date Filed
Q4 2024 91 $496M +$19.6M -$59.9M -$40.3M AL, ISRG, CDNA, ENSG, WGS 13F-HR 1/23/2025, 06:09 PM
Q3 2024 102 $504M +$32.4M -$51.4M -$19M CDNA, ENSG, AL, ISRG, WGS 13F-HR 11/12/2024, 06:02 AM
Q2 2024 97 $444M +$37.5M -$19M +$18.4M AL, CDNA, ENSG, ISRG, PCRX 13F-HR 8/14/2024, 12:59 PM
Q1 2024 98 $423M +$27.9M -$30.8M -$2.89M AL, ENSG, CDNA, ISRG, PCRX 13F-HR 5/13/2024, 05:16 PM
Q4 2023 102 $417M +$13.6M -$28.8M -$15.2M AL, ENSG, CDNA, ISRG, PCRX 13F-HR 2/14/2024, 05:15 PM
Q3 2023 104 $399M +$7.86M -$35.1M -$27.3M AL, ENSG, ISRG, NVGS, PCRX 13F-HR 11/14/2023, 04:06 PM
Q2 2023 97 $481M +$10.6M -$11.3M -$677K AL, ENSG, ISRG, PCRX, PROF 13F-HR 8/8/2023, 05:23 PM
Q1 2023 112 $476M +$58.3M -$101M -$42.7M AL, ENSG, NVGS, PCRX, CDNA 13F-HR 4/10/2023, 04:08 PM
Q4 2022 94 $432M +$11.5M -$15.5M -$3.99M AL, ENSG, PCRX, NVGS, PROF 13F-HR 2/7/2023, 03:42 PM
Q3 2022 100 $454M +$30.3M -$14.9M +$15.3M PCRX, AL, ENSG, CDNA, NVGS 13F-HR 11/14/2022, 03:40 PM
Q2 2022 99 $476M +$34.8M -$7.69M +$27.1M PCRX, AL, ENSG, NVGS, CDNA 13F-HR 8/1/2022, 04:31 PM
Q1 2022 101 $612M +$59.9M -$17.4M +$42.5M PCRX, AL, CDNA, ENSG, NVGS 13F-HR 5/9/2022, 05:09 PM
Q4 2021 104 $665M +$50.1M -$27.4M +$22.7M AL, AOSL, CDNA, PCRX, ENSG 13F-HR 2/8/2022, 03:06 PM
Q3 2021 112 $673M +$82.9M -$56.7M +$26.2M CDNA, AL, PCRX, ENSG, AOSL 13F-HR 11/12/2021, 04:43 PM
Q2 2021 111 $704M +$65.3M -$55.9M +$9.34M CDNA, AL, ENSG, AMRC, PCRX 13F-HR 7/28/2021, 02:05 PM
Q1 2021 108 $657M +$58.9M -$60M -$1.07M CDNA, AL, ENSG, PCRX, GFN 13F-HR 5/14/2021, 05:22 PM
Q4 2020 97 $623M +$28.8M -$10.5M +$18.2M CDNA, AL, AMRC, ENSG, LL 13F-HR 2/12/2021, 03:17 PM
Q3 2020 98 $468M +$25.6M -$8.05M +$17.6M CDNA, AL, PCRX, ENSG, AMRC 13F-HR 11/12/2020, 03:10 PM
Q2 2020 90 $413M +$16.2M -$24M -$7.78M CDNA, AL, PCRX, AMRC, ENSG 13F-HR 8/13/2020, 04:51 PM
Q1 2020 95 $294M +$27M -$56.6M -$29.6M CDNA, AL, ENSG, AMRC, PCRX 13F-HR 5/11/2020, 04:05 PM
Q4 2019 93 $457M +$30.2M -$14.1M +$16.1M AL, GFN, CDNA, EVBG, FIVN 13F-HR 2/14/2020, 03:08 PM
Q3 2019 95 $422M +$12.5M -$13.7M -$1.21M AL, CDNA, GFN, ENSG, FIVN 13F-HR 11/8/2019, 03:10 PM
Q2 2019 97 $464M +$37.9M -$10.5M +$27.4M CDNA, AL, ENSG, EVBG, GFN 13F-HR 8/12/2019, 04:05 PM
Q1 2019 97 $459M +$54.1M -$15.4M +$38.6M CDNA, AL, ENSG, EVBG, GFN 13F-HR 5/13/2019, 04:10 PM
Q4 2018 93 $376M +$42.1M -$21.8M +$20.3M CDNA, AL, GFN, ENSG, EVBG 13F-HR 1/18/2019, 03:12 PM
Q3 2018 101 $435M +$83.6M -$19.4M +$64.2M CDNA, GFN, AL, ENSG, EVBG 13F-HR 11/13/2018, 04:21 PM
Q2 2018 96 $337M +$46.3M -$11.3M +$35.1M GFN, CDNA, AL, LL, RHT 13F-HR 8/9/2018, 04:31 PM
Q1 2018 93 $279M +$9.68M -$26.9M -$17.2M AL, RHT, GFN, CDNA, AMRC 13F-HR 5/9/2018, 05:12 PM
Q4 2017 91 $282M +$18.5M -$13.8M +$4.73M AL, GFN, CDNA, RHT, FIVN 13F-HR 2/13/2018, 01:51 PM
Q3 2017 95 $269M +$28.8M -$22.4M +$6.37M AL, RHT, LL, FIVN, SU Restatement 11/14/2017, 04:25 PM
Q2 2017 87 $218M +$38.6M -$14.7M +$23.8M AL, LL, FIVN, AMBR, GFN 13F-HR 7/20/2017, 02:55 PM
Q1 2017 92 $228M +$4.03M -$12M -$7.92M AL, LL, RHT, ATHN, GFNSL 13F-HR 5/11/2017, 04:36 PM
Q4 2016 91 $230M +$16.9M -$11.4M +$5.46M AL, RTEC, GFNSL, ATHN, AMBR 13F-HR 2/14/2017, 03:26 PM
Q3 2016 93 $232M +$56.3M -$9.46M +$46.9M AL, ATHN, AMBR, RTEC, LL 13F-HR 11/14/2016, 03:31 PM
Q2 2016 88 $207M +$34.9M -$4.45M +$30.5M ATHN, EQIX, AL, AMBR, RTEC Restatement 8/24/2016, 10:26 AM
Q1 2016 88 $209M +$21.8M -$14.9M +$6.84M AL, ATHN, EQIX, RHT, RTEC 13F-HR 5/3/2016, 03:44 PM
Q4 2015 83 $216M +$5.09M -$10.2M -$5.12M ATHN, RHT, AL, EQIX, RTEC 13F-HR 2/16/2016, 10:51 AM
Q3 2015 85 $204M +$13M -$44.1M -$31.1M RHT, EQIX, AL, ATHN, RTEC 13F-HR 10/16/2015, 11:19 AM
Q2 2015 86 $252M +$9.27M -$35.2M -$25.9M AL, RHT, EQIX, PSIX, ATHN 13F-HR 7/24/2015, 10:49 AM
Q1 2015 89 $299M +$22.8M -$23M -$216K AL, GFN, RHT, PSIX, EQIX 13F-HR 5/12/2015, 05:26 PM
Q4 2014 87 $295M +$38.6M -$8.07M +$30.5M GFN, EQIX, RHT, CTCT, AL 13F-HR 2/13/2015, 01:07 PM
Q3 2014 96 $297M +$32.5M -$22.2M +$10.3M GFN, EQIXXXXX, AL, ATHN, RHT 13F-HR 10/15/2014, 04:26 PM
Q2 2014 94 $291M +$22.8M -$31.3M -$8.55M GFN, AL, EQIXXXXX, CTCT, ATHN 13F-HR 7/31/2014, 01:25 PM
Q1 2014 102 $337M +$47.1M -$47.5M -$379K GFN, AL, ATHN, NVDQ, EQIXXXXX 13F-HR 5/6/2014, 04:26 PM
Q4 2013 95 $313M NVDQ, ATHN, AL, CTCT, RHT Restatement 2/6/2014, 12:38 PM